Alphabet Inc. is a Strong Buy after a 10% post-earnings drop, now trading at 17.5x forward earnings. Read more on GOOG stock ...

Alphabet nears low-case valuation after a selloff, with Cloud growth and a huge backlog boosting upside. Read here for an ...

Phreesia is rated Buy with a $14.8 price target, reflecting undervaluation versus peers and improving profitability. Click ...

Viking Therapeutics is advancing VK2735, a dual GLP-1/GIP agonist for obesity, with Phase 3 injection results expected in ...

Alphabet is rated Buy with a $325 12-month price target, reflecting 15% upside from current levels. Read more on GOOG stock ...

With midterms coming up next week, it’s important to remember that as hard as it may be, history shows that it’s not ...

Honeywell Aerospace is rated Buy at $160, driven by a robust $19.3B order backlog and anticipated production improvements.

PepGen stays a hold, after a major problem with its released data from the phase 2 FREEDOM2-DM1 study using the PGN-EDODM1 ...

Nvidia, Amazon, and Microsoft exemplify how large, sustained R&D and capital investments can drive innovation in ...

Novartis is rated Hold, with a 12-month price target of $141.81, implying a 12.0% downside from the current share price. Read ...

Global markets have become a minefield, an especially precarious circumstance, considering the unprecedented scope of ...

Celestica is a leader in the ethernet switching market, allowing them to partake in the TAM expansion to $173B by 2030. Learn ...